Frequency Therapeutics Inc expected to post a loss of 36 cents a share - Earnings Preview

Reuters

Aug 05, 2023

* Frequency Therapeutics Inc is expected to show no change in quarterly revenue when it reports results on August 7 (estimated).

*

* Refinitiv's mean analyst estimate for Frequency Therapeutics Inc is for a loss of 36 cents per share.

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

* The mean earnings estimate of analysts was unchanged in the last three months.

* Wall Street's median 12-month price target for Frequency Therapeutics Inc is $4, above its last closing price of $0.73.

Previous quarterly performance (using preferred earnings measure in US dollars).

QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI

ENDING ARTESTIMAT IBES MET, SE %

E® ESTIMATE MISSED

Mar. 31 2023 -0.41 -0.42 -0.55 Missed -30.8

Dec. 31 2023 -0.57 -0.63 -0.49 Beat 22.3

Sep. 30 2022 -0.56 -0.57 -0.55 Beat 3.4

Jun. 30 2022 -0.70 -0.67 -0.61 Beat 9.4

Mar. -0.62 -0.63 -0.67 Missed -5.5

31 2022

Dec. 31 2021 0.59 0.15 -0.62 Missed -506.8

Sep. 30 2021 -0.52 -0.57 -0.73 Missed -27.2

Jun. 30 2021 -0.51 -0.51 -0.52 Missed -2.3

This summary was machine generated August 5 at 02:07 GMT. All figures in US dollars unless otherwise stated.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2357495517"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2357495517\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2357495517?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-08-05 10:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2357495517","market":"us","top_or_hot":-1,"title":"Frequency Therapeutics Inc expected to post a loss of 36 cents a share - Earnings Preview","media":"Reuters","content":"<html><body><p>* Frequency Therapeutics Inc     is expected to show no change in quarterly revenue when it reports  results on August 7 (estimated). </p><p>   * </p><p>   * Refinitiv's mean analyst estimate for Frequency Therapeutics Inc is for a loss of 36 cents per share. </p><p>   * The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy,\" 2 \"hold\" and no \"sell\" or \"strong sell.\"  </p><p>   * The mean earnings estimate of analysts was unchanged in the last three months. </p><p>   * Wall Street's median 12-month price target for Frequency Therapeutics Inc is $4, above its last closing price of $0.73. </p><p>Previous quarterly performance (using preferred earnings measure in US dollars). </p><p>QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI</p><p>ENDING        ARTESTIMAT  IBES                 MET,    SE %</p><p>              E®          ESTIMATE             MISSED  </p><p>Mar. 31 2023  -0.41       -0.42      -0.55     Missed  -30.8</p><p>Dec. 31 2023  -0.57       -0.63      -0.49     Beat    22.3</p><p>Sep. 30 2022  -0.56       -0.57      -0.55     Beat    3.4</p><p>Jun. 30 2022  -0.70       -0.67      -0.61     Beat    9.4</p><p>Mar.        -0.62       -0.63      -0.67     Missed  -5.5</p><p>31 2022                                                </p><p>Dec. 31 2021  0.59        0.15       -0.62     Missed  -506.8</p><p>                                                       </p><p>Sep. 30 2021  -0.52       -0.57      -0.73     Missed  -27.2</p><p>Jun. 30 2021  -0.51       -0.51      -0.52     Missed  -2.3</p><p>This summary was machine generated August 5 at 02:07 GMT.  All figures in US dollars  unless otherwise stated.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Frequency Therapeutics Inc expected to post a loss of 36 cents a share - Earnings Preview</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFrequency Therapeutics Inc expected to post a loss of 36 cents a share - Earnings Preview\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2023-08-05 10:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>* Frequency Therapeutics Inc     is expected to show no change in quarterly revenue when it reports  results on August 7 (estimated). </p><p>   * </p><p>   * Refinitiv's mean analyst estimate for Frequency Therapeutics Inc is for a loss of 36 cents per share. </p><p>   * The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy,\" 2 \"hold\" and no \"sell\" or \"strong sell.\"  </p><p>   * The mean earnings estimate of analysts was unchanged in the last three months. </p><p>   * Wall Street's median 12-month price target for Frequency Therapeutics Inc is $4, above its last closing price of $0.73. </p><p>Previous quarterly performance (using preferred earnings measure in US dollars). </p><p>QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI</p><p>ENDING        ARTESTIMAT  IBES                 MET,    SE %</p><p>              E®          ESTIMATE             MISSED  </p><p>Mar. 31 2023  -0.41       -0.42      -0.55     Missed  -30.8</p><p>Dec. 31 2023  -0.57       -0.63      -0.49     Beat    22.3</p><p>Sep. 30 2022  -0.56       -0.57      -0.55     Beat    3.4</p><p>Jun. 30 2022  -0.70       -0.67      -0.61     Beat    9.4</p><p>Mar.        -0.62       -0.63      -0.67     Missed  -5.5</p><p>31 2022                                                </p><p>Dec. 31 2021  0.59        0.15       -0.62     Missed  -506.8</p><p>                                                       </p><p>Sep. 30 2021  -0.52       -0.57      -0.73     Missed  -27.2</p><p>Jun. 30 2021  -0.51       -0.51      -0.52     Missed  -2.3</p><p>This summary was machine generated August 5 at 02:07 GMT.  All figures in US dollars  unless otherwise stated.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2357495517","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2357495517","pubTimestamp":1691201342,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"* Frequency Therapeutics Inc     is expected to show no change in quarterly revenue when it reports  results on August 7 .    *    * Refinitiv's mean analyst estimate for Frequency Therapeutics Inc is for a loss of 36 cents per share.    * The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy,\" 2 \"hold\" and no \"sell\" or \"strong sell.\"     * The mean earnings estimate of analysts was unchanged in the last three months.    * Wall Street's median 12-month price target for Frequency Therapeutics Inc is $4, above its last closing price of $0.73. Previous quarterly performance . QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRIENDING        ARTESTIMAT  IBES                 MET,    SE %              E          ESTIMATE             MISSED  Mar. 31 2023  -0.41       -0.42      -0.55     Missed  -30.8Dec. 31 2023  -0.57       -0.63      -0.49     Beat    22.3Sep. 30 2022  -0.56       -0.57      -0.55     Beat    3.4Ju","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"Frequency Therapeutics公司预计每股亏损36美分","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FREQ":0.9},"content_text":"* Frequency Therapeutics Inc     is expected to show no change in quarterly revenue when it reports  results on August 7 (estimated).    *    * Refinitiv's mean analyst estimate for Frequency Therapeutics Inc is for a loss of 36 cents per share.    * The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy,\" 2 \"hold\" and no \"sell\" or \"strong sell.\"     * The mean earnings estimate of analysts was unchanged in the last three months.    * Wall Street's median 12-month price target for Frequency Therapeutics Inc is $4, above its last closing price of $0.73. Previous quarterly performance (using preferred earnings measure in US dollars). QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRIENDING        ARTESTIMAT  IBES                 MET,    SE %              E®          ESTIMATE             MISSED  Mar. 31 2023  -0.41       -0.42      -0.55     Missed  -30.8Dec. 31 2023  -0.57       -0.63      -0.49     Beat    22.3Sep. 30 2022  -0.56       -0.57      -0.55     Beat    3.4Jun. 30 2022  -0.70       -0.67      -0.61     Beat    9.4Mar.        -0.62       -0.63      -0.67     Missed  -5.531 2022                                                Dec. 31 2021  0.59        0.15       -0.62     Missed  -506.8                                                       Sep. 30 2021  -0.52       -0.57      -0.73     Missed  -27.2Jun. 30 2021  -0.51       -0.51      -0.52     Missed  -2.3This summary was machine generated August 5 at 02:07 GMT.  All figures in US dollars  unless otherwise stated.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}